Abstract:Objective To evaluate the value of ultrasonic quantitative method in the diagnosis of liver fibrosis in chronic hepatitis B (CHB) patients. Methods Ultrasonography was performed in 186 CHB patients who underwent liver biopsies. Fifteen indices including liver capsule thickness and fourteen texture parameters of gray level co-occurrence matrix were extracted from standard sonograms and compared with fibrosis stages by histopathology. The status of liver fibrosis was divided into five stages from S0 to S4 by histopathology based on the disease severity. ANOVA and Spearman correlation analysis were applied to analyze the differences and relationships between these indices and pathological stage, respectively. Then discriminant analysis models were established based on the indices for quantitative diagnosis of liver fibrosis. Results Among the fifteen indices, including liver capsule thickness, only the variance (F=0. 55, r=0. 06; both P＞0. 05), sum average (F=0.61, both r=0.05 ; P＞0.05), sum entropy (F=1.68, r=0.09; both P≥0.05) and entropy (F=1.39,r=0.12; both P＞0.05) were not significantly associated with the stages and not manifested linear correlation. Using biopsy results as gold standard, the correct rank rate of discriminant analysis model analysis in the patients staged from S0 to S4 were 80. 0%, 64. 9%, 61.3%, 74. 1% and 80.6 %, respectively. There were 73.1% of cross-validated cases who were accurately classified by the model analysis. The sensitivity, specificity and accuracy in patients with stage ≥ 1 were 97. 6%,80.0% and 91.9%, respectively; those in patients with stage≥2 were 92.1%, 89.7% and 90.9%,respectively; those in patients with stage≥3 were 94.8%, 96.1% and 95.7%; and those in patients with stage 4 were 80. 6%, 97.4 % and 94.6%, respectively. When considered S0 as no fibrosis, S1 as mild fibrosis, S2 and S3 as moderate to severe fibrosis and S4 as early cirrhosis, the consistence rates between discriminant analysis model and biopsy result were 81.7%, 78. 4%, 56. 9% and 90.3%,respectively. There were 74.7% of cross-validated cases who were correctly classified. The sensitivity, specificity and accuracy of the models for determining the fibrosis severity in patients≥mild fibrosis were 97.6%, 81.7% and 92.5%, respectively; those in patients ≥ moderate to severe fibrosis were 83. 1%, 94.8% and 89.2%, respectively; those in patients with early cirrhosis were 90.3%, 93.5% and 93.0%, respectively. Conclusion As a novel and noninvasive method, ultrasonic texture analysis could quantitatively determine liver fibrosis in CHB patients and is worthy of further investigation.

Evaluating the value of entecavir to the early cirrhosis by acoustic structure quantitative technology

The application value in early liver cirrhosis by acoustic structure quantification technology

The value of acoustic structure quantification technology in grading liver fibrosis in patients with chronic hepatitis B

Preliminary study on the quantitative diagnosis of liver cirrhosis by acoustic structure quantification technology

Correlation Between Serum Entecavir Concentration And Virological Response In Patients With Chronic Type B Hepatitis

The Value of Ultrasonic Elastographic Parameters in the Evaluation of Chronic Hepatitis B Liver Fibrosis

The value of diagnosis of acoustic structure quantification in grading liver fibrosis

Correlation of quality of life with aspartate aminotransferase-to-platelet ratio index,liver stiffness measurement, and histopathology after antiviral therapy for chronic hepatitis B liver fibrosis

Chronic Hepatitis B Patients with High Liver Fibrosis Levels Should Receive Antiviral Treatment.

Clinical value of real-time elastography quantitative parameters in evaluating the stage of liver fibrosis and cirrhosis.

Evaluation on the value of ultrasonic quantitative method in diagnosing liver fibrosis in chronic hepatitis B patients

Association Between Hepatic Steatosis And Entecavir Treatment Failure In Chinese Patients With Chronic Hepatitis B

Clinical Study Onqishen Erlian Decoction Combined with Entecavir for Patients with Liver Fibrosis of Hepatitis B

[Diagnostic Value of Endoscopic Ultrasonography, Fibroscan, Acoustic Radiation Pulse Imaging, Serological Index, and Their Combination for Early Stage Liver Cirrhosis].

[Combined anluohuaxianwan and entecavir treatment significantly improve the improvement rate of liver fibrosis in patients with chronic hepatitis B virus infection].

Antiviral Effects of Entecavir in Patients with Hepatitis B Virus-Induced Decompensated Liver Cirrhosis

Histological Outcome for Chronic Hepatitis B Patients Treated with Entecavir Vs Lamivudine-Based Therapy.

Longitudinal Monitoring of Liver Stiffness by Acoustic Radiation Force Impulse Imaging in Patients with Chronic Hepatitis B Receiving Entecavir.

Acoustic Structure Quantification Versus Point Shear Wave Speed Measurement for the Assessment of Liver Fibrosis in Viral Hepatitis B.

Effect of entecavir on IL-6/STAT3/SOCS3 pathway in patients with chronic hepatitis B-induced liver fibrosis

Efficacy Evaluation of Direct Antiviral Drugs Against Hepatitis B Virus in Improving the Degree of Liver Fibrosis